Aviva announced on 18 March 2026 that it was extending its AI underwriting summarisation tool to individual critical illness insurance applications. The tool supports the handling of medical reports by turning information into a form that underwriters can review. The announcement concerns individual protection, rather than a confirmed deployment across group employee-benefit contracts.
The distinction matters to employers and advisers assessing changes in insurance administration. A tool used in one product or workflow cannot be assumed to operate identically elsewhere. Claims about speed and consistency should remain attributed to the insurer rather than presented as independently established performance results.
Understand the task being assisted This editor recommends distinguishing the summarisation of information from the judgement made using that information. A concise medical summary may help a reviewer locate relevant material, but the programme needs a clear account of what is included, what may be omitted and when the underlying report must be consulted.
Benefits buyers can ask providers to explain where similar tools are used in their own services. The useful questions concern the actual workflow, the people responsible for decisions and the evidence used to assess quality. General statements about AI capability are less informative than a description of the task performed.
Assess quality alongside speed A review of the process should consider how errors or incomplete summaries are identified and corrected. Faster handling is one operational measure; it does not establish that the decision is accurate or that a customer receives a better outcome. Quality assurance needs to match the consequences of the information being processed.
The organisation can also examine how complex cases are handled and how a reviewer can challenge a summary. Clear escalation arrangements help distinguish assistance with a document from reliance on a result that cannot readily be checked.
Keep the customer explanation usable People applying for protection may need to understand how medical information is used and who can resolve a question about the process. An explanation should describe the service in terms that relate to the application, rather than substitute technical language for meaningful information.
Aviva’s announcement offers a concrete example of AI entering medical-information workflows. For benefits teams, its value is as a basis for informed provider questions. It does not establish a change to group coverage, prove clinical improvement or remove the need to assess the controls supporting an underwriting process.
Sources: Source consultée [1]
Share this:
- More [3]
